Roughly 41,500 PGY-1 positions. More than 44,800 registered applicants. A match rate near 93 percent for U.S. MD seniors, and closer to 58 percent for non-U.S.-citizen international graduates. The 2024 Main Residency Match was the largest on record, and buried inside those numbers is a decision thousands of applicants face every March in a compressed, stressful window: take the one-year preliminary position, or take the categorical spot.
I am going to make a case that might irritate some advisors: this is a probability problem, not a prestige problem. The right choice is the one with the higher expected value after you account for match odds, opportunity cost, and downstream match performance. A preliminary year is a one-year clinical bridge, full intern workload, no guaranteed continuation. A categorical spot is a direct contract through completion of residency. Everything else is commentary on those two facts.
Here are the metrics we will use to compare them: match rates, specialty fill patterns, attrition risk, reapplication rates, and program characteristics. Let us get to work.
What Match Data Can and Cannot Tell You
Match data is descriptive. It tells you what happened to large groups of people in prior cycles. It does not tell you what will happen to you. That distinction sounds obvious, and applicants ignore it constantly.
The sources worth your time:
- NRMP Results and Data reports, overall match rates by applicant type, specialty fill rates, and SOAP volumes.
- Charting Outcomes, the distributions that matter most: Step 2 CK means, research output, and match rates by specialty for your applicant category.
- SOAP outcome data, a window into which positions the market did not want and who ends up taking them.
- Program-level fill history, whether a specific program fills early, fills in the SOAP, or chronically converts prelims into categorical spots.
Now the traps, because there are three that wreck otherwise careful analysis. First, small sample sizes. A program that converted four of four prelims into categorical slots last year has shown you four events. That is anecdote wearing a lab coat. Second, self-selection bias. Applicants who take prelim years differ systematically from those who take categorical spots, different scores, different specialty targets, different risk tolerance. Comparing their outcomes as if the groups were interchangeable produces garbage conclusions. Third, year-to-year variability. Competitiveness shifted noticeably for emergency medicine between 2022 and 2024; anyone projecting 2021 assumptions onto the current cycle would have been badly wrong.
Key Metrics to Compare When Choosing Prelim vs Categorical
Strip the decision down to three metric families.
1. Probability of reaching your endpoint. For the categorical path, this is roughly the program's completion rate, high, typically well above 90 percent in most specialties once you are in the door. For the prelim path, it is a chain of conditional probabilities: the probability of converting to an advanced or PGY-2 spot, plus the probability of a successful reapplication if conversion fails. Multiply a chain of 60 to 70 percent events together and the product gets small fast. That arithmetic is the entire argument against casual prelim optimism.
2. Risk metrics. Three numbers matter: the likelihood you will need to reapply, the probability you will have to relocate (prelims frequently require a second move, and moving costs money and support systems), and your exposure to an unmatched year after the prelim ends. That last one is the scenario applicants refuse to model. Model it.
3. Specialty-specific competitiveness indicators. Pull the current Charting Outcomes for your target specialty and compare yourself honestly. In recent cycles, matched MD seniors in plastic surgery averaged around 260 on Step 2 CK with well over 20 research items; family medicine matched applicants sat in the low 240s with modest research expectations. Program volume matters too, a specialty with 1,800 positions absorbs borderline applicants; one with 80 does not.
A clarification on the chart above: these are illustrative ratings, not published NRMP values. They summarize the direction of the comparison. The prelim path wins on exactly one dimension, flexibility, and loses on continuity, security, risk, and time. If you take a prelim, you should be doing it deliberately for that flexibility, with a plan to cash it in.
When the Data Favors a Prelim Year
The prelim year makes numerical sense in a defined set of scenarios, and only in those scenarios.
- Your current specialty odds are weak, but a specific, fixable variable explains why. A missing Step 2 score, no U.S. clinical experience, a late specialty switch with zero letters in the field. A prelim year that directly repairs the deficiency changes your inputs for the next cycle.
- You need an interim year while building a credible application. This works when the year produces measurable output: strong in-training evaluations, U.S. letters from academic faculty, publications, networking at an institution that actually matches people like you.
- You are positioning for a specialty switch and the prelim gives you exposure, mentorship, and a letter pipeline in the new field.
Here is the pattern I have watched play out across multiple cycles: the applicants who convert prelim years successfully treat the year as a data-generation exercise. They know in July exactly which three numbers in their file will look different by September. The ones who fail treat the prelim as a waiting room. They reapply with the same file plus twelve months of generic intern service, and the market gives them the same answer. Same inputs, same outputs.
The warning sign is simple. If you cannot state, in one sentence, which measurable weakness the prelim year fixes, the data argues against taking it. Reapplicants as a group match at rates well below first-time seniors, historically 25 to 35 percentage points lower for U.S. graduates re-entering the Match, so the baseline you are fighting is not friendly. And note what the NRMP does not publish: any clean, reassuring statistic on prelim-to-categorical conversion rates. That absence is itself information.
When the Data Favors a Categorical Spot
The categorical position's advantage is structural: it converts your application into a full training contract. One signature eliminates the reapplication market entirely. No second ERAS cycle, no second interview season, no second exposure to the match-rate cliff that reapplicants face.
The efficiency argument compounds. Every additional application cycle costs application fees, interview travel, and months of administrative labor. More importantly, every year spent in training limbo defers a year of attending-level practice at the back end of your career. The opportunity cost is invisible in March and obvious in hindsight.
Now the harder question, because this is where applicants make emotional errors: how do you evaluate a categorical offer at a lower-prestige program against a prelim at a big-name institution? Objectively. The data shows that fellowship placement and job prospects track performance, letters, and board scores far more reliably than program brand in most specialties. A resident who finishes at a solid community internal medicine program with strong evaluations has options. A prelim at a famous hospital who fails to convert has a résumé line and a problem.
I will state the position directly: a categorical seat at a mid-tier program with an 80 percent-plus expected value beats a glamorous prelim strategy whose probability-adjusted outcome sits at 55 percent. Prestige is not a metric. It is a feeling, and feelings do not match you.
A Practical Decision Framework for Applicants
Here is the five-step method I would run on any real offer.
Step 1: Estimate your specialty match likelihood. Pull Charting Outcomes for your applicant category and target specialty. Locate your Step 2 score, research output, and any red flags against the matched and unmatched distributions. If you sit below the 25th percentile of matched applicants, your honest probability is poor, under 40 percent in competitive fields.
Step 2: Assign probabilities to next-year outcomes under each path. For the categorical path: completion probability, roughly 0.90 or better. For the prelim path: P(convert to PGY-2) + P(reapply successfully) × P(apply | conversion fails). Use base rates from NRMP reports, then adjust modestly for your specific plan. Do not let the adjustment exceed 10 points without a concrete reason.
Step 3: Compute expected value. Multiply each outcome by its probability and a rough value score, completed training in a specialty you will practice scores highest, an unmatched year scores near zero. Compare the two totals.
Step 4: Apply a personal threshold. My rule: if the categorical expected value exceeds the prelim expected value by a meaningful margin, call it 15 to 20 percentage points of outcome probability, take the categorical spot and do not look back. Below that margin, the prelim's flexibility may justify the risk, provided Step 5 passes.
Step 5: Run the final checklist.
- Specialty competitiveness relative to your file
- Strength of the backup plan if the prelim does not convert
- Financial runway for a possible second application cycle
- Geographic constraints and their effect on your reapplication pool
- Genuine willingness to reapply, not tolerance, willingness
Key Takeaways
- The data shows that the best choice is usually the one with the higher expected value, not the one with the most perceived prestige.
- A prelim year is strongest when it functions as a measurable bridge to a better next cycle; without that bridge, the risk profile rises quickly.
- Categorical spots generally offer more certainty and fewer hidden costs, and that stability often outweighs speculative upside.
Summary
Run the numbers before you run the decision. The categorical path wins on continuity, security, and time efficiency in almost every modeled scenario; the prelim path wins on flexibility and nothing else. That flexibility has real value, but only when it is attached to a specific, measurable improvement plan that changes your inputs for the next cycle. Estimate your probabilities honestly, compute the expected value of both paths, apply your threshold, and commit. The Match rewards applicants who treat their own careers with the same analytical rigor they would bring to any other dataset.
